The media is promising the public a quick fix for obesity via the new class of weight loss drugs, but in a rush to promote headlines, they’re leaving out some essential information for patients. These drugs must be taken for life and combined with diet and exercise, but our instant gratification public wants results without effort.
The most important job of any DTC team is selling DTC internally to people who need help understanding its importance. Our job is to educate the skeptics by helping them understand how and why people are making treatment decisions. Here are some helpful pointers.
Americans are not happy with our healthcare and its costs. PBMs, insurers, hospitals, and prescription drugs all take their toll on a for-profit healthcare system that focuses on the balance sheets, not patients. Despite this, Americans still refuse to make the sacrifices needed to prevent chronic healthcare problems. There are no easy answers, but finally, Congress is set to tackle the rising costs.
A new study is changing everything, finding that obesity significantly increases a person’s risk of death. A researcher from CU Boulder warns that obesity raises a person’s risk of death by anywhere from 22 to a staggering 91 percent. And what are we doing about it? Nothing
The private healthcare industry is enormous, notoriously challenging to navigate, and making a lot of money at the expense of the public. The industry enjoys massive profits, often by undermining public programs and exploiting patents, whose ruthless pursuit of money usually has life-threatening consequences. It maybe time to end for-profit healthcare.
(Fierce Pharma) A fresh slice of data from Standard Media Index suggests that might be the case, revealing spending on linear TV fell for the first time in years and that digital’s share of the media mix passed 50%. Here are the reasons for the decline.
Company culture has an enormous effect on productivity and, ultimately, shareholders. There is a direct correlation between company culture and the number of employees; the bigger the company, the worse the company culture. Preparing the company for the imminent changes coming to healthcare should be a top priority, but it’s not.
The FDA calls drug approval a “balancing act” between acceptable risks and benefits on its website. The FDA’s approval process may favor drug companies over consumers, and FDA approval does not guarantee safety. Big Pharma pays for the majority of drug safety reviews, provides the FDA with safety data for the review and has the option to have drugs approved faster with fewer clinical trials.